XML 22 R11.htm IDEA: XBRL DOCUMENT v3.19.1
Cash, Cash Equivalents, Marketable Securities and Restricted Cash
3 Months Ended
Mar. 31, 2019
Cash, Cash Equivalents, and Short-term Investments [Abstract]  
Cash, Cash Equivalents, Marketable Securities and Restricted Cash
Cash, Cash Equivalents, Marketable Securities and Restricted Cash
 
As of March 31, 2019, the Company held $96.3 million in cash and cash equivalents and $342.0 million of available-for-sale debt securities which are reported at fair value on the Company's consolidated balance sheets. Unrealized holding gains and losses are reported within accumulated other comprehensive loss in the statements of comprehensive loss. If a decline in the fair value of a marketable security below the Company's cost basis is determined to be other-than-temporary, such marketable security is written down to its estimated fair value as a new cost basis and the amount of the write-down is included in earnings as an impairment charge.
 
The Company regularly invests excess operating cash in deposits with major financial institutions, money market funds, notes issued by the U.S. government, as well as fixed income investments and U.S. bond funds, both of which can be readily purchased and sold using established markets. The Company believes that the market risk arising from its holdings of these financial instruments is mitigated as many of these securities are either government backed or of the highest credit rating. Investments that have original maturities greater than three months but less than one year are classified as current, while investments that have maturities greater than one year are classified as long-term.
  
Cash, cash equivalents and marketable securities are classified as current unless mentioned otherwise below and consisted of the following:
 
 
As of March 31, 2019
(in thousands)
Cost
 
Gross
unrealized
Gain
 
Gross
unrealized
Loss
 
Fair
Value
Cash and cash equivalents
$
96,349

 
$

 
$

 
$
96,349

Corporate debt securities, current portion
138,194

 
96

 
(6
)
 
138,284

Commercial paper
134,948

 
52

 
(7
)
 
134,993

Asset-backed securities
68,278

 
30

 
(8
)
 
68,300

Money market
350

 

 

 
350

Certificates of deposit
51

 

 

 
51

 
$
438,170

 
$
178

 
$
(21
)
 
$
438,327

Included in cash and cash equivalents
$
96,349

 
$

 
$

 
$
96,349

Included in marketable securities, current and non-current
341,821

 
178

 
(21
)
 
341,978

Total cash, cash equivalents and marketable securities
$
438,170

 
$
178

 
$
(21
)
 
$
438,327

 
 
As of December 31, 2018
(in thousands)
Cost
 
Gross
unrealized
Gain
 
Gross
unrealized
Loss
 
Fair
Value
Cash and cash equivalents
$
79,749

 
$

 
$

 
$
79,749

Corporate debt securities, current portion
240,969

 
7

 
(250
)
 
240,726

Commercial paper
115,245

 

 
(104
)
 
115,141

Asset-backed securities
68,215

 
4

 
(84
)
 
68,135

Money market
350

 

 

 
350

Certificates of deposit
51

 

 

 
51

 
$
504,579

 
$
11

 
$
(438
)
 
$
504,152

Included in cash and cash equivalents
$
79,749

 
$

 
$

 
$
79,749

Included in marketable securities
424,830

 
11

 
(438
)
 
424,403

Total cash, cash equivalents and marketable securities
$
504,579

 
$
11

 
$
(438
)
 
$
504,152


 
For the three months ended March 31, 2019 there were no realized gains. For the fiscal year ended December 31, 2018, there were nominal realized gains. The cost of securities sold is based on the specific identification method.
 
Unrealized loss positions in the available-for-sale debt securities as of March 31, 2019 and December 31, 2018 reflect temporary impairments that have been in a loss position for less than twelve months and as such are recognized in other comprehensive gain (loss). The fair value of these available-for-sale debt securities in unrealized loss positions was $100.4 million and $403.1 million as of March 31, 2019 and December 31, 2018, respectively.
 
The following table provides a reconciliation of cash and cash equivalents and restricted cash reported within the consolidated balance sheets that sum to the total of the same such amounts shown in the Company's consolidated statements of cash flows.

(in thousands)
March 31, 2019
 
December 31, 2018
 
March 31, 2018
 
December 31, 2017
Cash and cash equivalents
$
96,349

 
$
79,749

 
$
114,322

 
$
49,060

Restricted cash
2,579

 
2,626

 
2,230

 
2,177

Cash and cash equivalents and restricted cash shown in the statement of cash flows
$
98,928

 
$
82,375

 
$
116,552

 
$
51,237